Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
July 9, 2025
The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials.
The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials.
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a rare and progressive type of heart failure, according to a new study. The model is the first and only AI tool of its kind.
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how doctors determine the best treatment for cancer patients—by enhancing how tumor samples are analyzed in the lab.
Researchers from DZNE, Ludwig-Maximilians-Universität München (LMU), and Technical University of Munich (TUM) have found that the enzyme “gamma-secretase”—implicated in Alzheimer’s disease and cancer—selects its reaction partners according to a complex scheme of molecular features.
It can take as long as 18 months for children with suspected autism spectrum or attention-deficit-hyperactivity disorders to get a diagnostic appointment with a psychiatrist in Indiana. But an interdisciplinary team led by an Indiana University researcher has developed a new diagnostic approach using artificial intelligence that could speed up and improve the detection of neurodivergent disorders.
A combination of high-resolution imaging and machine learning, also known as artificial intelligence (AI), can track cells damaged from injury, aging, or disease, and that no longer grow and reproduce normally, a new study shows.
A new study from Karolinska Institutet shows that artificial intelligence (AI) combined with portable digital microscopy improves the detection of intestinal worm infections, so-called soil-transmitted helminth (STH) in resource-limited settings.
PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight Dx—its digital pathology image management system—for use in primary diagnosis in clinical settings.
A new AI model is much better than doctors at identifying patients likely to experience cardiac arrest. The linchpin is the system’s ability to analyze long-underused heart imaging, alongside a full spectrum of medical records, to reveal previously hidden information about a patient’s heart health.
PARIS and SAN FRANCISCO, July 2, 2025 /PRNewswire/ — Moon Surgical, today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for two major advancements to its Maestro System: connectivity of the platform to power the Maestro Insights product and a Predetermined Change Control Plan (PCCP) to evolve its AI-powered ScoPilot product.